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Improving testing and uptake to careamong highly impacted populations is
a critical element of Seek, Test, Treat and
Retain strategies for reducing HIV inci-
dence in the community. HIV dispro-
portionately impacts prisoners. Though,
incarceration provides an opportunity to
diagnose and initiate therapy, treatment
is frequently disrupted after release.
Though model programs exist to support
linkage to care on release, there is a lack
of scalable metrics with which to assess
adequacy of linkage to care after release.
The linking data from Ryan White
program Client Level Data (CLD) files
reported to HRSA with corrections
release data offers an attractive means of
generating these metrics. Identified only
by use of a confidential encrypted Unique
Client Identifier (eUCI) these CLD files
allow collection of key clinical indicators
across the system of Ryan White funded
providers. Using eUCIs generated from
corrections release data sets as a linkage
tool, the time to the first service at
community providers along with key
clinical indicators of patient status at
entry into care can be determined as
measures of linkage adequacy. Using this
strategy, high and low performing sites
can be identified and best practices can be
identified to reproduce these successes in
other settings.
Though effective antiretroviral therapy
(ARV) has markedly improved life expec-
tancy for those living with HIV, efforts to
reduce new HIV infections in the US have
been significantly less successful. Indeed,
HIV incidence has been stable since 1991.
Calls for expanding universal testing and
treatment for HIV have been made based
on models which suggest that aggressive
expansion of HIV testing and treatment, a
strategy now termed “Seek, Test, Treat
and Retain,” may dramatically lower HIV
incidence.1 The recent trial HPTN 052
which demonstrated a profound reduction
in HIV transmission through antiretroviral
therapy provided to infected persons
provides key evidence to support the
potential impact of these expanded testing
and treatment strategies on new incident
infections in the community.2 The success
of this strategy will depend on the ability
of testing programs to identify and engage
in care the 25% of persons who do not
know their HIV status.3
Since the early years of the HIV epide-
mic, HIV has disproportionately impacted
prisoners. In 2008, the HIV prevalence
was 1.6% among the state prisoners, repre-
senting 20,449 people.4 It is estimated that
approximately 150,000 HIV-infected per-
sons, 14% of all Americans with HIV, pass
through corrections each year.5,6 The pre-
valence of HIV within correctional settings
ranges from 2.5 to more than three times
that of the general population with preval-
ence in high prevalence communities such as
Baltimore and Washington DC as high as
6.6%.4,6,7 Following release from prison,
former inmates are often marginalized in
their communities due to addiction, mental
health disorders, unemployment and racial
disparities, which can lead to decreased
access to health care.8,9 Incarceration is
often the only time these individuals access
HIV testing, education, counseling and
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treatment services.10 With as many as a
quarter of HIV-infected individuals are
unaware of their status, incarceration repre-
sents an important opportunity to provide
testing and treatment for a high risk,
underserved population.10
Periods of incarceration represent both
opportunities and, as they reenter the
community, challenges for those living
with HIV.11,12 Incarceration may provide
an opportunity to establish persons in care
and to initiate therapy in an observed and
highly structured manner. The success of
antiretroviral therapy in these settings may
account for a portion of the decline in
AIDS related deaths among prisoners.13
For those from medically underserved
communities, the healthcare received in
corrections may be markedly better than
that available to them in the community.
Disturbingly, the benefits of HIV-care in
prison, however, may not extend beyond
the prison gates as released prisoners often
have difficulty accessing community HIV
care in a timely manner.14-17 In studies of
those reincarcerated following release into
the community, CD4 counts were shown
to be lower and viral loads higher at the
time of follow-up than at last assessment
prior to release.14,18 Among HIV infected
prisoners leaving corrections in Texas,
only 5% were found to fill antiretroviral
prescriptions in time to avoid an interrup-
tion in care.16 In this same study, only
30% had filled prescriptions by 60 d post
release suggesting very significant inter-
ruptions in antiviral treatment.
The reason for the delays in connecting
people to care upon release in a timely
fashion are not entirely clear, but may
involve a number of community-based
factors including inadequate care resources
in the community, delays in reinstating
public and private health care benefits,
social stigmatization of persons with HIV
and other challenges surrounding re-
entry.19 In a representative sample from
four states, 75% of former inmates were
found to have no public or private
insurance 2 to 3 months after release.19
Additionally, during the transition back
to the community, former inmates are
faced with a number of personal challenges
which may obstruct their timely linkage to
care. These include locating secure hous-
ing, finding employment, reestablishing
ties with family members and in many
cases coping with substance use and
mental health problems.19-21
African Americans and Hispanics are
incarcerated at rates six and two times
those of whites, respectively.22 Similarly,
African Americans and Hispanics face
seven and three times the respective rates
of HIV infection as whites.23 The twin
epidemics of HIV/AIDS and incarceration
are intricately interrelated; incarceration
may contribute to and compound racial
disparities in HIV infection.24-26 The 2010
National AIDS Strategy calls for reduction
in HIV incidence and reductions in racial
disparities in HIV infection.27 Expanding
linkage to HIV care following release from
correctional settings therefore represents a
prime opportunity for addressing racial
disparities in HIV infection in the US.28
Though model programs to support
linkage to care exist in some areas of the
country, there is no systematic framework
for evaluating linkage to HIV care and
supporting the development of programs
to improve linkage to HIV care on a larger
scale.29-34 Development of metrics which
measure prisoner’s linkage to community
HIV care may offer an empirical starting
point for identifying best practices for
supporting HIV-positive prisoners’ healthy
and successful return to the community.
This article reviews the problem of assess-
ment of linkage to care and proposes a
framework for the development of such
metrics based on available corrections and
clinical care data sets.
Assessing the Adequacy
of Linkage to Care
Adequacy of linkage to care is defined both
in terms of the timeliness and the quality
of care received by former prisoners on
reentry. Time to receipt of first service is
the most basic metric of timeliness of care
following release. This metric requires a
means of linking corrections release data
for HIV-positive prisoners with the dates
of services of received in the community.
More informative measures could be
generated if data are available describing
the former prisoner’s health status at the
time of their first clinic visit. This strategy
has been used in prior evaluations of
outcomes for released prisoners with
HIV.14 Data regarding the clinical status
at the time of release, where available,
may be important as well to allow more
accurate assessment of changes in clinical
status prior to their initial care visit in the
community. Though virologic suppression
and CD4 count remain priority indicators
of health status, it is also important to con-
sider the adequacy of treatment of mental
health and substance abuse disorders after
release given the profound impact that these
comorbid conditions can have on outcomes
for patients living with HIV. Demonstrat-
ing the success of linkage to ancillary care
services may give some indication of the
quality of care in the community.
Linking corrections and outpatient
clinical care data are challenging at
multiple levels. Protections exist around
the confidentiality of information related
to HIV status that may limit the ability to
access information of HIV infected per-
sons both from corrections and from
outpatient care settings. In addition, at
the time of release, individuals may not
have identified their site for HIV care in
the community. For those with prior
relationships with providers, at the time
of release they may relocate to other
geographic areas or change providers based
on the loss of insurance. Identifying the
site of initial follow-up therefore, may
require pooling data from multiple pro-
viders in the community. Lastly, the use of
aliases and misreporting of other personal
identifiers such as birth date makes
systematic linkage between data sets
without a common identifier challenging.
The three largest public payers of HIV
care are the federal-funded Medicare and
federal- and state-funded Medicaid entitle-
ment programs, and the discretionary
Ryan White HIV/AIDS Program.35,36
The Ryan White HIV/AIDS Program is
the only federal program which is solely
designed to support services with people
with HIV/AIDS. Unlike the entitlement
programs, Ryan White is designed to be
a “payer of last resort” and specifically
targets uninsured and underinsured HIV-
infected individuals. This includes indivi-
duals who have not yet progressed to
advanced HIV disease, thereby meeting
disability requirements for the entitlement
programs. Although not the largest public
program for HIV care, Ryan White is
320 Virulence Volume 3 Issue 3
the major source of care for recently
released inmates because this population
often lacks health insurance (including
Medicaid) and, especially if maintained
on HAART throughout incarceration,
released inmates are often too healthy to
qualify for HIV-related disability.37 In
addition to providing direct support for
ambulatory medical care services, Ryan
White funds may support the cost of
medications through the AIDS Drug
Assistance Programs (ADAP) and funding
other wrap-around services such as case
management, mental health, substance
abuse treatment, oral health, housing and
other ancillary care services.
Starting in 2009, all Ryan White
funded HIV/AIDS care programs were
required to submit client level data to
the Health Resources and Services
Administration (HRSA) for reporting.
The goal of these submissions is to obtain
a single, unduplicated count of all persons
receiving care from Ryan White providers
across the nation. The reporting of client
level data on HIV care through the Ryan
White HIV/AIDS Program represents an
unprecedented opportunity to evaluate, in
tremendous detail, the care provided and
client health outcomes across Ryan White
CARE sites. Given that HIV care in many
locations reflects the complementary effort
of multiple independent providers, the
aggregation of client-level data across
clinical sites allows for the development
of metrics which reflect the quality of care
across an entire system.
Optimal Record Linkage Strategy
An optimal strategy to match and link
records between prison and community
databases would allow for a high level of
accuracy in record matching across data-
bases while preserving the confidentiality
of the patients whose data are being
accessed. In order to assure scalability of
the linkage strategy, this strategy would
need to require only the minimum of
invested effort on the part of the com-
munity care and correctional sites. In order
to support the amalgamation of client level
data across Ryan White funded care sites,
HRSA developed a strategy for linking
records based on the use of an encrypted
Unique Client Identifer (eUCI). This
identifier is generated using the first and
third characters of the first and last names,
the full date of birth, and the gender which
are combined and encrypted using a secure
hash algorithm SHA-1 developed by the
National Security Agency.38,39 This algori-
thm has the important property that once
the encryption has taken place, the source
identifiers cannot be reconstructed from
the encrypted identifier, thus maintaining
the confidentiality of individual patients.
Though developed for use with the
Ryan White care program, the algorithm
for generation of the eUCI can be applied
to any data set containing name and birth
date data. Generation of eUCIs in both
correctional prisoner-release data, which is
public record, and Ryan White client-level
data, could provide a means to efficiently
and scalably link these data sets for the
generation of metrics of quality of linkage
to care. Use of aggregated incarceration
data through the Bureau of Justice
Statistics National Corrections Reporting
Program would minimize the need for
multiple independent requests to correc-
tional systems.
In small scale testing, the reported false
positive and false negative error rates are
3.8% and 5% respectively.39 False positive
matches occur when the same eUCI is
generated for persons for different indivi-
duals. False negative matches occur when
two eUCIs are generated for a single
individual based on differences in record-
ing of their name, date of birth or gender.
Though identifiers including segments of
the social security number were considered
as part of strategies to make the eUCI,
collection of social security numbers at
clinical care sites raised confidentiality con-
cerns and risked deterring some patients
from care. In addition the improved
accuracy of the match based on SSN (where
available) would be offset by the potential
for reductions in accuracy based on incom-
plete or inaccurate reporting of SSN. Given
that the level of error achieved with the
implemented eUCI was deemed acceptable
by HRSA for quality review and reporting,
the final identifier was based on name, date
of birth and gender only.
Obtaining accurate linkages between
corrections release data and aggregated
community clinical care data poses some
unique challenges. The deliberate use of
aliases among populations involved with
the criminal justice system is common.
Inconsistencies in recorded birthdates,
variable patterns of hyphenation in names,
and the use of maiden names by female
prisoners have also been frequently noted.
Since these are key components of the
eUCI these variations may have a signifi-
cant impact on the observed error rates
when using the eUCI for matching. A
linkage strategy that incorporates genera-
tion of eUCIs based on aliases and other
potential modifications of the name may
be important to minimize the number of
false negative linkages.
The tolerance for error in linkage
assessments will vary based on the goals
of the assessment. In order to establish a
precise estimate of the success of linkage to
care, a high level of linkage accuracy is
required. This level of accuracy may not be
achievable using the eUCI or other similar
scalable metrics. Nonetheless, linkage
strategies with higher error rates may still
be useful as a means to distinguish high
performing and low performing sites. As
shown in Table 1, even with error rates
substantially beyond the 8.8% combined
false positive and false negative error rate
reported from the HRSA validation, high
performing sites could be distinguished
from low performing sites with manage-
able samples sizes. Given the use of
aliases by persons in corrections and other
potential inconsistencies in the recording
of data between the correctional and
clinical data systems, we expect that false
negative matches will be more prominent
than false positives though this assumption
needs to be validated.
Metrics of Linkage Adequacy
and Best Practices
Once data sets have been linked, effective
metrics for assessing linkage adequacy need
to be developed. These metrics should
include measures of both time to linkage
and the quality of linkage as reflected in
the clinical status of the releasee at the
time of the first encounter and the types
of services obtained. Key indicators
could include detectable viremia for those
meeting CD4 criteria for treatment,
time to fulfillment of first antiviral pre-
scription, as well as receipt of ancillary case
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management, substance abuse or mental
health services where that data are avail-
able. Because the need for ancillary services
will not be documented in release records,
it will not be possible to draw conclusions
regarding failure to link to necessary
services. High rates of linkage to ancillary
services if correlated with high performing
sites may suggest that these are important
components of a successful strategy for
linkage to care. Immunologic status and
detectable viremia at follow-up, time to
follow-up and time to filling of ARV
prescriptions have been used as measures
of adequacy of linkage to care in prior
studies. Where clinical data are available
from the time of release, declines in CD4
count can be an additional indicator of
linkage failure.
Measures of linkage adequacy using this
strategy could be utilized in multiple ways.
Serial measures at a given site would allow
program managers to assess the success of
linkage programs and interventions as
well. Comparing quality measures across
sites and across regions would allow
identification of model programs and best
practices which could potentially be repli-
cated at other sites. Lastly, generation of
regional or national statistics regarding the
adequacy of linkage may provide impor-
tant feedback for policy development
related to correctional health and HIV.
Tracking Linkage in a Changing
Healthcare Environment
Although Ryan White funded care pro-
grams are likely the first point of contact
on reentry in most jurisdictions, access
to other public and private insurance
programs as a result of healthcare reform
may significantly change this in the years
to come. A linkage strategy validated
using Ryan White care data could
similarly be applied to aggregated client
level data from other data sources or even
multiple data sources. The confidentiality
protection inherent in the use of the
eUCI as a linkage strategy would be key
in negotiating access to alternate clinical
data sets. Other potential sources of data
for linkage include Medicaid programs,
state health programs such as Mass Health,
pharmacy prescription data, data from
the Veterans Administration health sys-
tem, and urgent care and emergency care
providers, and state or national laboratory
surveillance data (see Fig. 1). Each of
these data sets would include the
necessary information to generate the
eUCI and details of specific services
funded or tracked through those programs.
If accurate matching can be performed
across data sets, the potential for aggrega-
tion of data from multiple data sources in
a manner that would create a composite
picture of all the services received by
an individual, enhancing the accuracy of
linkage estimates.
Evaluating Reasons for Variability
in Linkage Success
Once metrics are established for linkage to
care, both from a research and from a
quality and program planning point of
view follow-up investigations will need to
be performed to identify the differences in
performance between sites and within a
site over time. This may include quanti-
tative investigation of determinants of
adequacy of linkage to care. Qualitative
research that thoroughly explores the social
processes and factors that influence how
and whether inmates are effectively linked
to care is an important complement to
these analyses. First, qualitative analyses
may help unpack and explain the observed
linkage trends. Second, qualitative analyses
will also help reveal how the “macro” level
factors such as the local and national
policy environments, resources, health
infrastructure, leadership and other insti-
tutional factors impact access to care upon
release. For example, focus groups and
interviews with Ryan White Care pro-
viders and correctional administrators may
illustrate the local factors and policies that
explain linkage trends. Similarly, qualita-
tive analyses that explore the inmates’
experiences with treatment and care ser-
vices upon release may help highlight
the “micro” or individual-level factors
that affect inmates’ continuity in care.
These might include substance abuse,
stable housing, health insurance status,
mental health, employment and other
factors. In summary, qualitative research
is an essential and complimentary com-
ponent of understanding trends in linkage
to care services for recently released
inmates, and may help shed light on social
factors and processes not observed in
quantitative trends alone. Taken together,
the quantitative and qualitative investi-
gations will inform efforts to develop
Table 1. Simulated linkage estimates by true linkage rate and net error rate
Net Linkage
Error Rate*
High Performing Site Low Performing Site Sample Required to
Demonstrate Difference**
True Linkage Rate Linkage Estimate True Linkage Rate Linkage Estimate
-0.4 0.6 0.84 0.3 0.42 48
-0.3 0.6 0.78 0.3 0.39 57
-0.2 0.6 0.72 0.3 0.36 68
-0.1 0.6 0.66 0.3 0.33 81
0.1 0.6 0.54 0.3 0.27 116
0.2 0.6 0.48 0.3 0.24 139
0.3 0.6 0.42 0.3 0.21 170
0.4 0.6 0.36 0.3 0.18 210
*Defined as the percent of false negative links2false positive links. **Calculated based on the comparison of proportions by x2 test with continuity
correction, a = 0.05, power = 0.80
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effective programs supporting linkage to
care for persons on reentry.
Challenges and Opportunities
There are several key challenges to be
addressed in order to build a scalable
system of assessment of linkage to care on
entry. In order to be successful, a program
of systematic analysis of the adequacy
of linkage to care must be built in a
collaborative manner with input and
buy-in from all involved parties. This is
particularly important with regard to the
involvement of the correctional health
system which faces the ongoing challenge
of trying to provide the linkage services for
detainees who have complex psychosocial
needs, high rates of comorbid mental
illness and substance addictions, and
limited resources to care for themselves
post release. Maintaining this support on
the corrections side will require that
corrections officials be involved from the
outset in the review and dissemination of
data. Deficiencies identified need to be
addressed as systems challenges rather
than singular failings on the part of one
agency. Assuring optimal linkage to care
may require additional support for correc-
tional linkage programs and these analyses
may provide an important first step
in making the case to policymakers for
the need for additional support for
discharge planning within the departments
of corrections.
On the clinical side, assuring adequate
measures are taken to maintain con-
fidentiality is key. This involves the
development and validation of linkage
procedures that minimize disclosure of
personal identifiers and protected health
information. In addition, developing
strategies for data linkage that use aggre-
gated data either at the State or Federal
level will minimize the need for trans-
mission of data and thereby minimize
the risk of unintended disclosures. If
HRSA is able to link aggregated client
level data for all Ryan White funded
providers to corrections release data, this
would offer the real possibility that
assessment of linkage to care across
jurisdictions could become a standard
component of quality monitoring for
Ryan White care sites with a minimum
risk to confidentiality. Aggregation of
release data across correctional systems
would in a similar way enhance the
scalability of these linkage analyses. Use
of aggregated data from the federal correc-
tions system may provide a potential
model for the use of centralized corrections
data to assess linkage success across correc-
tional systems.
Conclusions
Reporting of client level data allows an
unprecedented opportunity to assess the
adequacy of linkage to care to newly
released HIV positives individuals.
Linkage of the Ryan White Client Level
Data to corrections release data may pro-
vide an important tool for the development
Figure 1. Linking correctional and clinical data sources to evaluate linkage to care for returning prisoners with HIV.
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of metrics of linkage adequacy that can
be used to monitor quality improvement
and program development. If proved
successful this strategy with the con-
fidentiality protections built into the use
of the eUCI can be used with other data
sets to evaluate service linkage across a
variety of care environments. Ultimately,
enhancing linkage to care services for
prisoners and recently released inmates
will likely contribute to several important
goals outlined in the 2010 National
AIDS Strategy, including reducing: HIV
incidence, reducing racial disparities in
HIV infection and AIDS-related adverse
health events. If individuals are success-
fully linked to care and maintained on
treatment, this strategy can contribute to
efforts to reduce community viral load
which may have demonstrable impacts on
HIV incidence.
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